Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 10398784 Nanoconjugates able to cross the blood-brain barrier

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
Date Filed
December 29, 2017
Date of Patent
September 3, 2019
Patent Applicant
Northwestern University
Northwestern University
Patent Application Number
15858142
Patent Citations Received
‌
US Patent 11957788 Multivalent delivery of immune modulators by liposomal spherical nucleic acids for prophylactic or therapeutic applications
0
‌
US Patent 10640539 Recombinant protein-based method for the delivery of silencer RNA to target the brain
‌
US Patent 11633503 Delivery of oligonucleotide-functionalized nanoparticles
0
‌
US Patent 11696954 Synthesis of spherical nucleic acids using lipophilic moieties
0
‌
US Patent 11364304 Crosslinked micellar spherical nucleic acids
‌
US Patent 11433131 Adoptive cell therapy using spherical nucleic acids (SNAs)
‌
US Patent 11866700 Liposomal spherical nucleic acid (SNA) constructs presenting antisense oligonucleotides (ASO) for specific knockdown of interleukin 17 receptor mRNA
0
Patent Inventor Names
Caroline H. Ko
0
Chad A. Mirkin
0
David A. Giljohann
0
Janina Luciano
0
Samuel A. Jensen
0
Alexander Stegh
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
10398784
Patent Primary Examiner
‌
Kimberly Chong

Find more entities like US Patent 10398784 Nanoconjugates able to cross the blood-brain barrier

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo